- $70 million of series 2010 hospital revenue bonds
- $37.75 million of series 2009 hospital revenue refunding bonds
The rating affirmation is based on a number of factors, including FH’s leading market position, improved operating profile and sound balance sheet.
The outlook is stable.
More articles on healthcare finance:
Riverside University Medical Center taps collection, billing agency
OIG: Vermont owes CMS $10.5M for botched ACA grants
22 rural Louisiana hospitals get Medicaid funding boost
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit